… (IL) is an intervention offered to patients with UVFP to alleviate … in patients with UVFP secondary
to cardiothoracic surgery … that CTS patients undergoing injection laryngoplasty for UVFP …

… Hoarseness associated with abrupt cardiac aggravation has been recorded in patients with
long-standing PDA, lending credence to the above assertion. 11,12) The degree of recovery …

… Finally, by reducing the risk of aspiration, inpatient injection laryngoplasty may allow inpatients
… Given that cardiothoracic surgical patients are often fragile and their pulmonary status is …

… in some cardiac patients. Additionally, … injection laryngoplasty may have been related to
the timing of the follow up VFSS, being 9 months after the procedure, at a time when the injected …

… Given the high proportion of cardiothoracic surgery patients in our cohort and the multiple
possible causes of chest radiologic abnormalities among these patients, only patients with …

… Most patients in this study had UVFI following cardiac surgery. Patients with congenital
cardiac disease may have other contributing factors that limit oral intake and increase the …

… the ideal timing of VF injection laryngoplasty in patients with postoperative VFMI and most
… in the current study were diagnosed with acute VFMI secondary to thoracic or cardiothoracic …

… Awake injection laryngoplasty (IL) is becoming increasingly utilized in the inpatient setting, …
option for patients with vocal fold immobility immediately following cardiothoracic surgery. …

… Patients injected in the acute setting have vocal outcomes … It can be hypothesized that patients
who do not receive injection … iatrogenic UVFP were from cardiothoracic surgery, followed …

… injection laryngoplasty has been associated with shorter LOS in our patient population. … Our
institutional practice of medialization shifted from type 1 thyroplasty to injection laryngoplasty …